1. Home
  2. TCBK vs EVO Comparison

TCBK vs EVO Comparison

Compare TCBK & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBK
  • EVO
  • Stock Information
  • Founded
  • TCBK 1975
  • EVO 1993
  • Country
  • TCBK United States
  • EVO Germany
  • Employees
  • TCBK N/A
  • EVO N/A
  • Industry
  • TCBK Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCBK Finance
  • EVO Health Care
  • Exchange
  • TCBK Nasdaq
  • EVO Nasdaq
  • Market Cap
  • TCBK 1.5B
  • EVO 1.6B
  • IPO Year
  • TCBK N/A
  • EVO 2021
  • Fundamental
  • Price
  • TCBK $44.05
  • EVO $4.44
  • Analyst Decision
  • TCBK Hold
  • EVO Buy
  • Analyst Count
  • TCBK 5
  • EVO 2
  • Target Price
  • TCBK $50.75
  • EVO $5.90
  • AVG Volume (30 Days)
  • TCBK 94.9K
  • EVO 44.7K
  • Earning Date
  • TCBK 01-23-2025
  • EVO 11-06-2024
  • Dividend Yield
  • TCBK 3.00%
  • EVO N/A
  • EPS Growth
  • TCBK N/A
  • EVO N/A
  • EPS
  • TCBK 3.46
  • EVO N/A
  • Revenue
  • TCBK $389,190,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • TCBK N/A
  • EVO $3.84
  • Revenue Next Year
  • TCBK $5.63
  • EVO $10.94
  • P/E Ratio
  • TCBK $12.73
  • EVO N/A
  • Revenue Growth
  • TCBK N/A
  • EVO N/A
  • 52 Week Low
  • TCBK $31.73
  • EVO $2.85
  • 52 Week High
  • TCBK $51.06
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • TCBK 48.02
  • EVO 49.82
  • Support Level
  • TCBK $43.90
  • EVO $4.40
  • Resistance Level
  • TCBK $45.07
  • EVO $4.49
  • Average True Range (ATR)
  • TCBK 1.05
  • EVO 0.10
  • MACD
  • TCBK 0.03
  • EVO -0.00
  • Stochastic Oscillator
  • TCBK 42.68
  • EVO 38.46

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of Treasury Management Services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: